About 500 reports

Abstract: - Global mRNA Vaccines Market to Reach $127.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for mRNA Vaccines estimated at US$64.9 Billion in the year 2021, is projected to reach a revised size of US$127.3 Billion by 2027, growing at a CAGR of 11.9% over the analysis...

  • Cancer Immunotherapy
  • Vaccine
  • World
  • China
  • United States

Types of mRNA Vaccine and Therapeutics

  • Therapy
  • Vaccine
  • World
  • APAC
  • Health Expenditure
  • Urban Population

mRNA Vaccines Market Report 2021-2031: Forecasts by Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Immune System, Other Treatment Type), by Type mRNA Vaccines (Non-Replicating mRNA, In-Vivo Self-Replicating mRNA, In-Vitro Non-Replicating mRNA, Other mRNA Type), by Application...

  • Vaccine
  • World
  • APAC

Global mRNA Vaccines and Therapeutics Market for COVID-19 Vaccines and Non-COVID-19 Vaccines to Reach $28.92 Billion and $1.69 Billion by 2025 and 2031, Respectively; BIS Research Study Market Report Coverage - mRNA Vaccines and Therapeutics Market Segmentation • Application – COVID-19...

  • Therapy
  • Infectious Disease
  • World

Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...

  • Therapy
  • Pathology
  • Infectious Disease
  • Vaccine
  • Clinical Trial
  • World
  • Cancer Incidence
  • Cause-Specific Mortality Rate

Report Scope: This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for mRNA therapeutics for the prevention of infectious diseases (through prophylactic vaccines) and treatment of chronic (e.g., cancer, heart diseases) and several other rare diseases. The...

  • Therapy
  • Infectious Disease
  • World
  • Infectious Disease Incidence
  • Chronic Disease Prevalence

Abstract: According to the new updated study on COVID-19 Vaccines by Global Industry Analysts (GIA), approximately 53% of world population will be fully vaccinated by the end of the year 2021. This figure is expected to increase to 81% by the year 2022. The rapid vaccination programmes launched around the world...

  • Vaccine
  • Infectious Disease
  • World
  • India
  • United States
  • United Kingdom
  • Vaccination Coverage
  • Cause-Specific Mortality Rate

RNA therapeutics is a rapidly expanding area of next-generation biological drugs.RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a...

  • Therapy
  • World

INTRODUCTION Medical researchers first began evaluating mRNA as a therapeutic modality in the 1990s. The clinical use of mRNA is presently being evaluated in both therapeutic (protein replacement therapies, and as an alternative to classical gene therapies) and preventive (mRNA vaccines) roles. There are over 65 mRNA therapeutics...

  • Therapy
  • Infectious Disease
  • APAC
  • Europe
  • North America
  • Health Provider Density

INTRODUCTION Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have been associated with concerns related to solubility and / or permeability. , In this context, considering modern regulatory standards, a large number of potential therapeutic leads...

  • Drug Delivery
  • Nanobiotechnology
  • Light Vehicle
  • World
  • APAC
  • Europe
  • North America

‘COVID-19 (Novel Coronavirus 19) - Therapeutic Pipeline for Vaccines - 2020’ report delivers an in-depth understanding of the Covid-19 therapeutic vaccines that are currently under development by various companies across the globe. It also highlights key emerging market trends across the globe with a major focus on key geographies like the...

  • Infectious Disease
  • World
  • China
  • Health Expenditure

This report provides a comprehensive overview of the size of the SARS-CoV-2 COVID Vaccine market, segmentation of the industry (by geography and vaccine technology), key players and the vast potential of vaccines that are in clinical trials. Kelly Scientific analysis indicates that the global COVID vaccine market was worth $59 billion in 2021....

  • Vaccine
  • World

Major players in the COVID19 vaccine and therapeutics pipeline analysis market are CanSino Biologics, Moderna, Inovio Pharmaceuticals, Regeneron, Gilead Sciences, GlaxoSmithKline, Medicago Inc., Sanofi, University of Oxford, and Altimmune. The COVID19 vaccine and therapeutics pipeline analysis market covered in this report is segmented...

  • Infectious Disease
  • Vaccine
  • World

The materials used for pharmaceutical vaccine packaging vary, and many are well-established in the market for the transport and storage of vaccines.Despite the wide variety, some of the most used vaccine packaging materials remain challenged by glass delamination, instability, and pH alteration over time. The global COVID-19 pandemic...

  • Packaging
  • Vaccine
  • World

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives)...

  • Infectious Disease
  • Middle East

Moderna itself claims that mRNA vaccines are better at mimicking natural infections, and highlights the agility of its manufacturing system.

  • Infectious Disease
  • Vaccine
  • World
  • Drug Approval
  • Infectious Disease Mortality

mRNA Vaccine

  • Infectious Disease
  • World
  • China
  • South Africa
  • Drug Approval
  • Infectious Disease Mortality

These mRNA vaccines need ultra-low temperature freezers as well.

  • Blood Supply
  • Pharmaceutical
  • Laboratory
  • Household Refrigerator
  • APAC
  • Household Refrigerator Sales
  • Energy Consumption

Global Neoantigen Cancer Vaccine Market is Projected to Reach $1826.1 Million by 2030 Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccine market? • What are the underlying structures resulting in the...

  • Cancer Immunotherapy
  • World

With this research service, our Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, recombinant...

  • Biopharmaceutical
  • World
  • Drug Approval

The behavioral rehabilitation market is estimated to register a steady CAGR of 3.5 % during the forecast period from 2021-2026. The COVID-19 pandemic is expected to have a slightly negative impact on the market. At present, countries across the world are facing a considerable threat of COVID-19 (coronavirus). Many pharmaceutical and...

  • Healthcare
  • World
  • Health Expenditure
  • Depression Prevalence

xvi Synthetic biology technologies such as DNA- and mRNA-based vaccine technologies allow researchers to read and write DNA quite readily and develop innovative vaccines easily.

  • Infectious Disease
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

INTRODUCTION Vaccines are versatile preventive formulations that have, so far, enabled the global eradication of smallpox (1980) and polio (2015), which are both debilitating viral diseases. According to the WHO, currently, global vaccination coverage is nearly 85%. This is believed to be responsible for preventing close...

  • Vaccine
  • World
  • APAC
  • Europe
  • Vaccination Coverage

“Exosomes - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 70+ pipeline drugs in Exosomes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule...

  • Therapy
  • Regenerative Medicine
  • World

A Non-Randomized, Open Label, Controlled, Dose-escalation, Phase I Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of One or Two Administrations of Candidate Rabies mRNA Vaccine CV## in Healthy Adult Subjects

  • Clinical Trial
  • World
  • APAC
  • G7

##. BioNTech and Pfizer join Phase III frontrunners with mRNA vaccine

  • Vaccine
  • Infectious Disease
  • United Kingdom
  • Cause-Specific Mortality Rate
  • Mortality Rate

• The therapeutic oligonucleotide market, which will be galvanized by the success of COVID-## messenger ribonucleic acid (mRNA) vaccines, is forecast to reach $##.##B by • The market for gene therapies, especially those using viral vectors, is expected to be slowed down by high cost of therapies, which may limit its accessibility.

  • Gene Therapy
  • United States
  • Japan
  • Europe
  • Drug Approval
  • Medical Technology Density

Sanofi Pasteur and Translate Bio have expanded their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases.

  • Cancer Immunotherapy
  • World
  • Middle East
  • Africa
  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Cancer Incidence
  • Health Expenditure

Sanofi Pasteur and Translate Bio have expanded their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases.

  • Cancer Immunotherapy
  • Europe
  • Cancer Incidence
  • Cancer Mortality

Sanofi Pasteur and Translate Bio have expanded their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases.

  • Cancer Immunotherapy
  • South America
  • Central America
  • Brazil
  • Cancer Incidence
  • Mortality Rate